Skip to main content
SpringerLink
Log in

Ulcerative Colitis Therapeutics: Immunotherapy and Antisense Are Coming

  • Perspectives
  • Published:
Pharmaceutical Innovation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ulcerative Colitis Therapeutics: Immunotherapy and Antisense Are Coming. Pharmaceutical Innovation 10, 51–53 (2001). https://doi.org/10.1007/BF03319086

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03319086

Keywords

Search

Navigation